Home › High Alpha In Shorting Infinity Pharmaceuticals With Potential Failure Of Upcoming Trials
 

Keywords :   


High Alpha In Shorting Infinity Pharmaceuticals With Potential Failure Of Upcoming Trials

2015-01-10 22:41:32| Biotech - Topix.net

Although Infinity has a collaboration agreement with AbbVie for IPI-145 in blood malignancies, I have doubts about the potential of the selective PI3K inhibitor following the failure in RA. If IPI-145 also fails in blood malignancies then Infinity is effectively worth only the cash on its balance sheet.

Tags: high potential failure alpha

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »